OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 24 filers reported holding ADMA BIOLOGICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2016$446,000,000
+57.6%
75,000
+114.3%
0.01%
+100.0%
Q1 2016$283,000,000
-4.1%
35,000
-3.8%
0.01%0.0%
Q4 2015$295,000,000
-3.0%
36,4000.0%0.01%
-16.7%
Q3 2015$304,000,000
-9.8%
36,4000.0%0.01%0.0%
Q2 2015$337,000,000
-16.2%
36,400
-11.2%
0.01%
-33.3%
Q1 2015$402,000,00041,0000.01%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders